Drug maker may face huge fines
"Off-label" use of prescription drugs is legal for doctors, but Eli Lilly ran afoul of the law, the Times reported, when it was discovered the company was actively promoting its drugs for non-FDA approved uses. That's an action drug manufacturers are, by law, not allowed to take.
Zyprexa alone accounts for $1.5 billion a year in states' Medicare and Medicaid spending. Any fines Eli Lilly might pay in the settlement would be distributed among the state and federal agencies that purchase Zyprexa. If the settlement goes through, it will be the biggest ever paid by a drug company for this type of infraction, the Times reported.